Contrast Enhanced Computed Tomography can predict the glycosaminoglycan content and biomechanical properties of articular cartilage  by Bansal, P.N. et al.
Osteoarthritis and Cartilage (2010) 18, 184e191
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.joca.2009.09.003Contrast Enhanced Computed Tomography can predict the
glycosaminoglycan content and biomechanical properties
of articular cartilage
P. N. Bansalyz, N. S. Joshix, V. Entezariy, M. W. Grinstaffzx* and B. D. Snydery*
yOrthopedic Biomechanics Laboratory, Beth Israel Deaconess Medical Center and
Harvard Medical School, Boston, MA, United States
zDepartment of Biomedical Engineering, Boston University, MA, United States
xDepartment of Chemistry, Boston University, MA, United States
Summary
Objective: An early hallmark of osteoarthritis (OA) is the progressive loss of glycosaminoglycans (GAGs), the extracellular matrix (ECM)
component of articular cartilage that confers it with compressive stiffness. Our aim in this work is to establish the feasibility of using Contrast
Enhanced Computed Tomography (CECT) with an anionic iodinated contrast agent e Cysto Conray II e as a minimally invasive tool to
measure the changes in the GAG content as well as the compressive stiffness of articular cartilage.
Methods: The GAG content of mated osteochondral plugs excised from bovine patello-femoral joints was progressively degraded using
chondroitinase ABC. The mated plugs were then immersed in an anionic, tri-iodinated contrast agent, imaged using peripheral quantitative
computed tomography (pQCT), subjected to an unconﬁned compressive stress relaxation test and the GAG content measured using 1,9-
dimethylmethylene blue (DMMB) assay. Partial correlation analysis was performed to compare the variation in X-ray attenuation measured
by pQCT to the variation in GAG content and in equilibrium compressive modulus.
Results: The X-ray attenuation of cartilage exposed to an anionic, tri-iodinated, contrast agent measured by quantitative computed tomogra-
phy (QCT) accounted for 83% of the variation in GAG content (r2¼ 0.83, P< 0.0001) and 93% of the variation in the equilibrium compressive
modulus (r2¼ 0.93, P< 0.0001).
Conclusion: Using a mated osteochondral plug model to evaluate the biochemical composition and biomechanical properties of cartilage, this
study demonstrates the interrelationships between X-ray attenuation, GAG content, and equilibrium compressive modulus, and that CECT can
be used to monitor and quantify changes in the GAG content and biomechanical properties of articular cartilage.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Hyaline cartilage is the load bearing tissue that supports
and evenly distributes mechanical loads across articular
joints and provides joints with a smooth, nearly frictionless
gliding surface. On a molecular level, the composition and
architecture of cartilage determine its tissue structural prop-
erties. Articular cartilage is comprised primarily of proteogly-
cans (5e10% wet weight.), type II collagen (10e20% wet
weight.) and water (68e85%). By binding interstitial water,
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184extracellular matrix (ECM), confer cartilage with its com-
pressive stiffness. Swelling of the ECM by bound water is
resisted by collagen ﬁbrils arranged in a dense network of
highly oriented ﬁbrils, and this network opposes the tensile
and shear forces applied to articular surfaces1,2.
Osteoarthritis (OA) is a disease that degrades articular
cartilage. It has been established that the concentration of
glycosaminoglycan (GAG) in cartilage is an indicator of car-
tilage health3. In early OA, GAGs are lost from the ECM and
this decrease in GAG concentration reduces the resilience
of articular cartilage to compressive loads4. Unfortunately,
this deterioration of articular cartilage occurs before a loss
of cartilage volume is evident radiographically5,6. Conse-
quently, imaging methods that can non-invasively or with
minimal invasiveness measure changes in the GAG content
and structural properties of articular cartilage before clinical
symptoms and radiological changes are evident may pro-
vide physicians with an important opportunity to diagnose
OA early. These methods will also be important to serially
evaluate the efﬁcacy of disease modifying drugs and
cartilage repair strategies.
185Osteoarthritis and Cartilage Vol. 18, No. 2Magnetic resonance imaging (MRI) has been used rou-
tinely to measure the thickness of cartilage and to observe
joint surface topography7e9. Several MRI-based techniques
(e.g., T2 mapping, T1rho, and 23Naþ mapping) have been
developed that quantitatively reﬂect the GAG and the colla-
gen content of articular cartilage10e15. The delayed gadoli-
nium enhanced magnetic resonance imaging of cartilage
(dGEMRIC) uses a contrast agent, gadolinium (Gd-
DTPA2), that acts as a mobile anionic probe that partitions
itself throughout the ECM in inverse proportion to the ﬁxed
negative charge density of the proteoglycans comprising
the ECM (Fig. 1). Since the T1 relaxation time is inversely
proportional to the concentration of Gd-DTPA2, the map-
ped T1 relaxation time is directly proportional to the concen-
tration and spatial distribution of GAG throughout the
articular cartilage. Studies have conﬁrmed that dGEMRIC
can differentiate between healthy and arthritic cartilage
both in vitro and in vivo16e22. However, there have been
conﬂicting reports as to the reliability of dGEMRIC for pre-
dicting the GAG concentration and compressive stiffness
of cartilage23e28. Further, widespread use of MRI-based
techniques to measure the earliest biochemical changes
in articular cartilage induced by OA has been hindered by
the high cost, long acquisition time and relatively low spatial
resolution of clinical MRI scanners, as well as the need for
specialized pulse sequences and software programs to an-
alyze and map the GAG content of cartilage.
Recently, following a procedure analogous to dGEMRIC,
quantitative computed tomography (QCT) has been used to
measure the concentration and spatial distribution of an an-
ionic, iodinated contrast agent diffused into isolated articular
cartilage explants29,30. Since the magnitude of Computed
Tomography (CT) attenuation is directly proportional to
the concentration of iodine partitioned throughout the
ECM, the Contrast Enhanced Computed Tomography
(CECT) attenuation is inversely proportional to the GAG
content of the cartilage. Apart from the radiation exposure
concerns with repetitive CT scans, CT imaging is less ex-
pensive, more widely accessible and able to achieve higher
spatial resolution over shorter acquisition times compared
to MRI. Moreover, advances in CT technology, such as he-
lical CT scanners using multiple row detectors, allow rapid
3D reconstruction and segmentation of cartilage and sub-
chondral bone without the need for specialized sequences.
Unconﬁned compressive stress relaxation tests have
been widely used as a standard method to evaluate the
equilibrium biomechanical properties of articular cartilage31.Fig. 1. An anionic contrast agent diffuses into articular cartilage matrix in i
GAGs. In healthy cartilage diffusion of the anionic contrast agent into the
depleted, more of the anionic contrast aIt is known that the GAGs are responsible for the static com-
pressive properties of articular cartilage4,32,33. Hence, it is
reasonable to hypothesize that the CT attenuation obtained
from CECT images can be used as a gauge of the static
mechanical properties of articular cartilage. The equilibrium
mechanical properties are commonly obtained by separat-
ing the cartilage surface from the subchondral bone. How-
ever, employing osteochondral plugs circumvents the
problems of curling and swelling that occur when cartilage
explants are separated from the subchondral bone. Further-
more, when cutting cartilage away from the subchondral
bone, it is possible that the deep zone cartilage absent
from the cartilage explant will affect the mechanical proper-
ties measured for that explant. Thus, using congruent and
conforming osteochondral plugs excised from opposing
joint surfaces may provide a more realistic model especially
for clinical applications of CECT to indirectly ascertain the
mechanical health of the joint, whereby two cartilage sur-
faces interact.
Consequently, obtaining information about the biochemi-
cal content and biomechanical properties of articular
cartilage is important for basic studies as well as clinical
applications. Herein we report the use of CECT with an
iodinated, anionic contrast agent to measure the GAG
content and compressive stiffness of articular cartilage.Materials and methodsSPECIMEN PREPARATIONA diamond tipped cylindrical cutter irrigated with 0.9% saline at room tem-
perature was used to extract mated, cartilage on cartilage, osteochondral
plugs (7 mm diameter) from opposing articular surfaces of the ﬁve patella-
femoral joints from 1 to 2 years old freshly slaughtered cows [Fig. 2(a)].
Due to the requirement of harvesting matched osteochondral pairs, we har-
vested between three and ﬁve pairs from the ﬁve patella-femoral joints.
These 15 pairs of mated osteochondral plugs were used in this study. Pairs
of conforming osteochondral plugs were randomly assigned to one of three
groups (ﬁve pairs/group): normal control or one of two GAG depleted groups
degraded by immersing the osteochondral plugs in chondroitinase ABC
(SigmaeAldrich, C3667, St. Louis, MO, USA) [0.1 U/mL in 50 mM Tris,
60 mM NaOAc, 0.02% BSA, pH 8.0] at room temperature for 8 or 30 h. At
the end of the digestion period the samples were washed twice in 200 mL
of 0.9% saline and then immersed in 7 mL of contrast agent, which signiﬁ-
cantly reduced the concentration of the enzyme to continue any further
digestion. Chondroitinase ABC is a GAG speciﬁc hydrolase that has been
used to deplete GAGs from ECM of articular cartilage34e36. This particular
enzyme was chosen, instead of other proteases like trypsin, because prelim-
inary studies indicated that it gave the most reproducible GAG degradation
patterns in the osteochondral plug samples and it has been shown to be
very speciﬁc for GAG and does not affect the collagen content37,38.nverse proportion to the ﬁxed negative charge density conferred by
matrix is limited due to the high GAG content. As GAG becomes
gent can partition into the matrix.
Fig. 2. (a) Mated pairs of conforming osteochondral plugs extracted from bovine patello-femoral joint where the highlighted region deﬁnes
where plugs were harvested (dashed lines). The mated patello-femoral plugs were randomly assigned to three groups (5 pairs/group).
(b) Schematic diagram showing the mechanical testing set-up. A e ﬁxture to hold the top plug, B e aluminum molds to concentrically
hold the plugs and pot with PMMA, C e chamber to hold bottom plug and saline, D e set screws to hold the aluminum molds in place,
E e physiologic saline.
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ionic, tri-iodinated contrast agent (Cysto Conray II, Mallinckrodt, MO, USA)
for at least 12 h to allow sufﬁcient diffusion time for the contrast agent to par-
tition itself throughout the ECM (see Supplementary material for details about
the diffusion time). A line proﬁle across the diameter of the plug conﬁrmed
that the contrast agent had completely diffused into the cartilage (see Sup-
plementary material, for a representative ﬁgure). Cysto Conray II contains
81 mg of iodine per mL and has a net charge of negative 1 [1]. The contrast
agent concentration was not altered from the commercial formulation
(81 mgI/mL and 0.213 M) and mixed with an antibiotic cocktail (0.01%
NaN3 and 10 mM EDTA) to prevent bacterial contamination. Cysto Conray
II has an osmolality of 403 mOsm/kg39,40, which is very close to the in situ
osmolality of articular cartilage (350e450 mOsm/kg)41. After blotting the car-
tilage surface to remove excess contrast agent, the plugs were positioned in
the gantry of the peripheral quantitative computed tomography (pQCT) scan-
ner (XCT Research SAþ, Stratec Medizintechnik GmbH, Pforzheim,
Germany) using a custom airtight holder which contained saline soaked
gauze to prevent drying of the cartilage. Four sequential, 100 mm thick, trans-
axial pQCT images were obtained at 70 mm in plane resolution and 1 mm in-
ter-slice distance. The image processing and thickness measurements were
performed using a commercial image processing software (Analyze, BIR,
Mayo Clinic, Rochester, Minnesota, USA). The CT data sets were imported
into Analyze and the cartilage was segmented from the subchondral bone
using a semi-automatic contour based segmentation algorithm. During the
segmentation process a seed point was placed in the region of interest
and a contour was ‘grown’ around the seed point until the region of interest
(cartilage) was segmented, the same process was applied to all the four sli-
ces. The mean thickness of the cartilage surface and mean X-ray attenuation
for cartilage was obtained by averaging over the four transaxial CT images.
The average CT attenuation in this study is reported in Hounsﬁeld Units (re-
fer Supplementary material for details on the Hounsﬁeld Value computation)
and was obtained without applying any thresholds or image manipulation.
The average CT attenuation was assumed to reﬂect the GAG content of
the tissue volume used in this study.MECHANICAL TESTINGTable I
Mean thickness data for each group used in the study. The data is
presented as mean standard deviation
Group Femoral groove
cartilage thickness in
mm (meanSD)
Patellar cartilage
thickness in
mm (mean SD)
Control 1.35 0.08 1.79 0.19
Degraded e 8 h 1.38 0.13 1.83 0.16
Degraded e 30 h 1.35 0.18 1.89 0.12Scans for representative samples in this study conﬁrmed that 6e8 h were
sufﬁcient to desorb the contrast agent from the cartilage. Hence, each pair of
osteochondral plugs was immersed in excess (15 mL) physiologic balanced
saline at room temperature overnight (w15 h) to desorb the contrast agent.
Using a custom built ﬁxture, each pair of osteochondral plugs was then
mounted co-axially in a mechanical testing machine (Instron 8511, Instron,
Norwood, MA, USA). The cartilage surfaces of both plugs were completely
immersed in saline [Fig. 2(b)] and incremental, stepwise compressive stress
relaxation tests were performed. An initial tare load of 0.25 N was applied
and allowed to ‘‘creep’’ to zero load to ensure congruent contact between op-
posing cartilage surfaces. A series of four, incremental, 5% strain steps were
applied to 20% of the total undeformed thickness of the mated cartilage sur-
faces42. The average thickness for the femoral and patellar cartilages was
1.36 0.19 mm and 1.84 0.19 mm respectively [mean standarddeviation] (Table I). After each strain step, the samples were allowed to relax
until the change in force was less than 0.05 N/min (<1250 Pa/min) (Fig. 3).
The equilibrium compressive modulus (Eeq) was obtained from the slope of
the line ﬁt to the equilibrium stress-strain data using a least-squares tech-
nique (MATLAB v7.6, Mathworks, Natick, MA, USA).DETERMINATION OF GAG CONTENTThe articular cartilage was separated from the subchondral bone using
a razor blade in order to obtain the wet mass of cartilage for each osteochon-
dral plug. The cartilage was lyophilized for 24 h and digested in papain
(0.5 mg/mL in 50 mM sodium phosphate, 1 mM EDTA, 2 mM DTT, pH 8.0
at 65C) for 24 h and then diluted 10e100 times for the 1,9-dimethylmethy-
lene blue (DMMB) colorimetric assay43. A GAG reference calibration curve
was generated using chondroitin-4-sulfate (SigmaeAldrich 27042, St. Louis,
MO, USA) dissolved in PBS at concentrations ranging from 10 to 100 mg/mL.
10 mL of each chondroitin-4-sulfate dilution was combined with 100 mL of
DMMB solution in a 96-well plate. The absorbance at 520 nm was measured
at each well using a plate reader (Beckman Coulter AD340, Fullerton, CA,
USA). From the linear regression generated from the GAG calibration curve
expressing absorbance at 520 nm as a function of chondroitin-4-sulfate con-
centration, the total GAG weight per mg wet weight of cartilage for each os-
teochondral plug was calculated.STATISTICAL ANALYSISNormality of the samples was determined by using the ShapiroeWilk test.
To account for multiple dependant samples across the groups, partial
correlation analysis was used to express the X-ray attenuation of the anionic
contrast agent partitioned throughout the cartilage measured by QCT as a lin-
ear function of the GAG content measured by the DMMB assay and of the
equilibrium compressive modulus (Eeq) measured mechanically. In addition,
the same associations were reported for CT attenuation vs GAG correlation
in the control group alone. The coefﬁcient of determination was used to test
the strength of each association. Only statistically signiﬁcant results,
P< 0.05, are reported. All statistical analyses were conducted using SPSS
17.0 (SPSS, Chicago, IL, USA).
Fig. 3. Stress relaxation response for articular cartilage from normal control group (left) and after exposure to chondroitinase ABC for 30 h
(right). Four incremental 5% strain steps (20% total cartilage thickness for each mated pair) were applied. After each strain step was applied,
the sample was allowed to relax until the change in the force was 0.05 N/min. The slope of the line (dotted line) connecting the equilibrium
force after every step was used to compute the equilibrium compressive stiffness.
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CONTENT OF CARTILAGEThe anionic, tri-iodinated contrast agent diffused into the
ECM of articular cartilage in inverse proportion to the GAG
content. The X-ray attenuation values increased with de-
creasing GAG content [Figs. 4 and 5(A)]. In degraded os-
teochondral plugs, the increase in X-ray attenuation was
most evident in the superﬁcial zone and less evident in
the deep zone of the articular cartilage (Fig. 4). In the Tolu-
idine-blue stained histological sections, the blue staining
progressively decreased with increasing GAG degradation
[Fig. 4(B)]. The change in X-ray attenuation was linearly
and inversely related to the GAG content of the articularFig. 4. CECT in bovine osteochondral plugs. (A) Representative CECT im
ABC for 8 h and for 30 h) demonstrate an increase in CT attenuation of ar
Representative Toludine-blue stained sections indicate a progressive losscartilage [r2¼ 0.83, P< 0.0001, Fig. 5(A)]. An equally high
correlation was observed between X-ray attenuation and
GAG content when the samples in only the control group
were compared separately (Fig. 6). Figure 6 shows that
CT attenuation predicts 83% of the variation in the GAG
content in the control group alone.COMPARISON OF EQUILIBRIUM COMPRESSIVE MODULUS
WITH GAG CONTENT OF CARTILAGEThe equilibrium compressive modulus (Eeq) was linearly
and directly related to the GAG content of the articular car-
tilage [r2¼ 0.89, P< 0.0001, Fig. 5(B)]. The GAG content
for this result was derived from the averaged GAG content
of the mated patellar and femoral osteochondral plugs (seeages of control and degraded samples (exposure to chondroitinase
ticular cartilage with increased exposure to chondroitinase ABC. (B)
of GAG (blue staining) from the ECM as indicated by CECT in (A).
Fig. 5. Linear regression plots: (A) CT attenuation vs GAG content measured by DMMB assay (individual plugs). (B) Equilibrium compressive
modulus vs GAG content measured by DMMB assay (pair mean). (C) Equilibrium compressive modulus vs CT Attenuation (pair mean). The
light shaded curve shows the 95% conﬁdence intervals for individual points and the dark shaded curve shows the 95% conﬁdence interval
curve for the mean.
188 P. N. Bansal et al.: Contrast Enhanced Computed TomographySupplementary material). 89% of the variation in the com-
pressive modulus of the articular cartilage was accounted
for by the variation in the GAG content of the ECM. The
equilibrium compressive modulus ranged from
0.69 0.19 MPa for the normal control osteochondral plugs
to 0.07 0.02 MPa for the GAG depleted osteochondral
plugs, which had been exposed to chondroitinase ABC for
30 h.COMPARISON OF X-RAY ATTENUATION WITH EQUILIBRIUM
COMPRESSIVE MODULUSThe change in X-ray attenuation was linearly and in-
versely related to the change in the compressive modulus
of the cartilage [r2¼ 0.93, P< 0.0001, Fig. 5(C)]. The X-
ray attenuation for this result was obtained by averaging
the CT attenuation for the patellar and femoral cartilage of
each pair.Fig. 6. Spatial distribution of GAG content as predicted by the cor-
relation plot of CT attenuation and GAG content for the control
group (n¼ 10). The light shaded curve shows the 95% conﬁdence
intervals for individual points and the dark shaded curve shows the
95% conﬁdence interval curve for the mean.Discussion
Minimally invasive diagnostic methods capable of mea-
suring early changes in the biochemical composition and
biomechanical properties of articular cartilage associated
with OA are clinically important for optimizing treatment pro-
tocols and assessing the efﬁcacy of chondroprotective
drugs and cartilage repair strategies. The variation in X-
ray attenuation produced by diffusion of an FDA approved,
tri-iodinated, anionic contrast agent into articular cartilage
matrix measured by QCT accounted for 83% of the variation
in GAG content in inverse proportion to the ﬁxed negative
charge density [Fig. 5(A)] and 93% of the variation in the
equilibrium compressive modulus [Fig. 5(C)] for mated os-
teochondral plugs excised from bovine patella-femoral
joints. The results for the GAG vs CT attenuation relation-
ship are consistent with the work of other investiga-
tors29,30,44,45 who demonstrated that the X-ray attenuation
of diffused iodinated anionic contrast agent into isolated ar-
ticular cartilage specimens measured by micro-CT and
pQCT was inversely correlated with the GAG content of
the articular cartilage. In a recent study44 it was demon-
strated that the X-ray attenuation of osteochondral plugs ex-
posed to an anionic, iodinated, contrast agent measured by
CT was negatively correlated with the GAG content of the
articular cartilage and that the subchondral bone did not al-
ter the diffusion of the contrast agent into articular cartilage
or interfere with the X-ray attenuation proﬁle of the contrast
agent in cartilage. However, none of these previously pub-
lished studies has established that the X-ray attenuation of
the diffused anionic contrast agent into the cartilage could
also be used to determine the equilibrium compressive
modulus of the cartilage in one consistent sample set46,47.
This work represents the ﬁrst to explicitly generate
a three-way correlation between CT attenuation, GAG con-
tent, and compressive modulus in one consistent sample
set.
In our study, the GAG content of the articular cartilage
measured by the DMMB assay accounted for 89% of the
variation in the equilibrium compressive modulus of the
mated osteochondral plugs [Fig. 5(B)]. In degraded
cartilage, it is possible that the diffusion of the contrast
agent may reﬂect changes in the permeability of the tissue
independent of changes in the negative ﬁxed charge
density48,49. The dependence of the compressive
189Osteoarthritis and Cartilage Vol. 18, No. 2properties of articular cartilage on its biochemical constitu-
ents and, speciﬁcally, on the GAG content has been previ-
ously established50e52. Nevertheless, there have also been
reports suggesting that the variation in mechanical proper-
ties across a joint surface may not be consistent with the
variation in proteoglycan content53. To also determine if
the water content was affecting the correlation, we deter-
mined the dry weight for all the cartilage samples and gen-
erated the corresponding correlation graphs. A subsequent
correlation plot between the GAG content normalized by
wet weight against the GAG content normalized by dry
weight gave an r2¼ 0.96 (see Supplementary material).
This result indicates that water content was not a strong
contributor to the correlation.
We evaluated the biomechanical properties of the articu-
lar cartilage using mated osteochondral plugs excised from
congruent and conforming surfaces of bovine patella-femo-
ral joints in an unconﬁned compressive stress relaxation ex-
periment. The cartilage surfaces during the mechanical
testing were treated as one composite stack of cartilage
being subjected to compressive stress relaxation42. The
mated osteochondral plugs simulate in vivo conditions
where, under compression, local deformation of conforming
chondral surfaces produces an interposed ﬂuid ﬁlm capable
of supporting the load and lubricating the cartilage-on-carti-
lage interface. The reported equilibrium compressive modu-
lus is a composite measure for the two opposing joint
surfaces. This is more indicative of the biomechanical state
of the opposing surfaces as observed in the clinic where the
health of joint is under investigation. To compare the values
of the equilibrium compressive modulus obtained with the
experimental procedure used in our study with the more
common procedure of measuring the equilibrium compres-
sive modulus using cartilage against an artiﬁcial surface
(metal or glass plate)10,26,27, we performed a series of addi-
tional mechanical experiments. The differences between
moduli obtained from the cartilage on cartilage and those
obtained from cartilage-on-steel were statistically insigniﬁ-
cant (P¼ 0.73) (see Supplementary material for further de-
tails). However, it is important to note that this method of
testing does not include the effect of thickness or deforma-
tion of each surface while determining the equilibrium mod-
ulus. Additional studies are underway to better characterize
this model.
In the present study, the diffusion kinetics may be differ-
ent than that found in vivo. However, CECT works by the
same physical principles as dGEMRIC, which has been
shown to measure successfully the GAG content and the
spatial distribution of GAG in whole joints ex vivo and
in vivo16e19. In clinical applications using dGEMRIC to
evaluate the articular cartilage of the hip and knee, repet-
itive loading of the joint enhanced the mass transfer of the
contrast agent into the cartilage by convection. Having
patients walk or actively move their limbs after injecting
the joint with an anionic, iodinated contrast dye could
accelerate the mass transfer of the contrast agent into
the cartilage in clinical applications. It should be noted
however, that the toxicity of the contrast agent should be
taken into account before advising patients to walk or
perform any activity that will result in signiﬁcant loads on
the tissue. This would be especially true for techniques
utilizing intra-articular injections.
The correlation between the gadolinium enhanced T1 in-
dex measured in cartilage by MRI and the mechanical prop-
erties of articular cartilage has been inconsistent. Using
indentation tests to measure the stiffness of human tibial
plateaus, the gadolinium enhanced T1 index correlatedwell with cartilage stiffness when T1 was computed at the
regions where the cartilage was indented25,28. However,
the T1 index value, when computed for the entire depth of
the cartilage did not correlate with the stiffness. Using stan-
dard unconﬁned compression tests to evaluate the mechan-
ical properties of cartilage, the gadolinium enhanced T1
index correlated well with compressive stiffness measured
in human26 and bovine articular cartilage specimens27.
However, there have been reports where the gadolinium
enhanced T1 index correlated poorly with the equilibrium
compressive modulus for patellar cartilage specimens23.
The lack of correlation between the gadolinium enhanced
T1 index and compressive modulus in some studies has
been attributed to the effect of collagen on the compressive
stiffness of cartilage and the effect of variations in collagen
content on the diffusion of gadolinium into the cartilage (es-
pecially in young animals and humans)24. The sensitivity of
CECT to the collagen content and collagen ﬁbril orientation
of articular cartilage will need further investigation espe-
cially with tissues from different species and at different
maturation stages. Nonetheless, in our study the X-ray at-
tenuation of the diffused anionic iodinated contrast agent
measured by QCT accounted for 93% of the variation in
the equilibrium compressive modulus.
With the increasing availability of multi-detector, helical
CT scanners, we believe that the higher resolution
(w200 mm) and faster acquisition times (w5 min) of these
instruments will enable CECT to be a viable alternative to
dGEMRIC and other MRI-based techniques for determining
cartilage health. Post-processing of sequential transaxial
CT images through whole joints allows the rapid generation
of segmented 3D reconstructions and tomographic 2D im-
ages of cartilage and subchondral bone without the need
for special sequences45. Since changes to the subchondral
bone architecture are also a hallmark of OA54e56, the ability
of CECT to simultaneously image the subchondral bone
morphology and articular cartilage surface layer adds to
the attractiveness of this technique. However, repetitive
scans using CECT may pose potential risks of radiation ex-
posure, especially for imaging of the hip.
In order to evaluate the potential of this technique to pre-
dict the spatial distribution of GAG content in the patello-
femoral surfaces used in this study, we correlated the
GAG content and the CT attenuation in the control group
alone. Figure 6 shows that CT attenuation predicts 83%
of the variation in the GAG content in the control group.
The signiﬁcant correlation shows that CECT is able to pre-
dict the narrow physiologic variation in the GAG content, but
this needs to be further validated in a larger cohort of sam-
ples from different sources and species.
The work presented here deﬁnes the interrelationships
between X-ray attenuation, GAG content, and equilibrium
compressive modulus as well as demonstrates that CECT
using an iodinated anionic contrast agent can quantify the
GAG content and compressive stiffness of articular carti-
lage in an ex vivo bovine osteochondral plug model.
Ex vivo studies using human and bovine cadaveric joints
and in vivo studies to monitor GAG loss are underway to
further validate the ability of CECT to monitor changes in
the GAG content and compressive modulus of articular
cartilage as a measure of cartilage health and disease.
Continued pre-clinical work using CECT based imaging pro-
cedures will facilitate the transition of this diagnostic method
to the clinic, where it can aid physicians in assessing the
biochemical and biomechanical health of articular cartilage
in order to monitor disease progression and to optimize
treatment protocols.
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